FIELD: organic synthesis. SUBSTANCE: invention provides novel difluoromethylene compounds of general formula I: (I), in which R1 is hydrogen atom or C1-C10-alkyl; R5 methyl or ethyl; R2 hydrogen atom or C1-C10-alkyl in alpha- or beta- position; R3 hydrogen or C1-C10-alkoxy in alpha- or beta-position; R4 hydrogen in alpha- or beta-position; A,B,D,E, and G each are hydrogen atom and, if necessary, at least one of substituent pairs G and R2, R2 and R4, R4 and A, A and R3, D and E form double bond. Compound I exhibit antioxidant and vessel-protection properties and can be used for treatment and prophylaxis of a variety of afflictions. EFFECT: expanded assortment of useful biologically-active compounds. 12 cl, 2 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
BRIDGE-CONTAINING ESTRATRIENES | 1990 |
|
RU2087479C1 |
17α-ALKYL-17β-HYDROXYESTRATRIENES, THEIR USING AND PHARMACEUTICAL PREPARATION | 2002 |
|
RU2285009C2 |
17 β -OXYESTRATRIENES | 2002 |
|
RU2339643C2 |
METHOD OF PRODUCING 7L-OR EXTRADIOLS | 0 |
|
SU677666A1 |
15,15-DIALKYLSTEROID COMPOUNDS AND METHOD OF PREPARATION THEREOF | 1994 |
|
RU2147306C1 |
14,17-C-BRIDGE STEROIDS AND PHARMACEUTICAL PREPARATION | 1995 |
|
RU2169153C2 |
METHOD OF OBTAINING 7-OXY-ESTRADIOLS | 0 |
|
SU676170A3 |
SULFAMATE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159774C2 |
0 |
|
SU514573A3 | |
19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
Authors
Dates
2000-09-10—Published
1996-03-13—Filed